Scholars Central

Conference abstractPublished 23 Nov 2012

A novel drug delivery system: Insulin free needle injection technology

Authors: Sanjay Reddy Akula, Jyothi Edla

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Diabetes mellitus is chronic, progressive systemic disease characterized by dysfunction insulin function. Physiological resistance to self injection or needle phobia has been seen across many populations in treatment of diabetes and require injectable products two or three times a day. A series of discoveries led to the development of the hypodermic needle which underwent significant changes. To overcome the problems related to needle based injections in treatment of diabetes there is one technology NFIT (Needle freed injectable technology).Needle free delivery is done conveniently both for solids and liquids. Various needle free injectors are available in the market like Biojector, vitajet, iject, cool.click etc. These formulations are designed for better acceptability and patient convenience. They offer less pain and no needle phobia. They are ideally suited to chronic injections of varying doses of insulin, proteins and monoclonal antibodies. And other novel drug formulations for diabetic patients i.e. insulin micro pump, insulin transdermal patches, insulin nanopump, insulin pen, insulin tablets, insulin capsules, insulin spray, inhalable insulin.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sanjay Reddy Akula”
  • BylineArticles whose byline prints “Jyothi Edla”